102 related articles for article (PubMed ID: 22378077)
1. Type-specific human papillomavirus DNA detected in atypical glandular cell Pap tests.
Mulhem E; Amin M; Copeland J; Sharma J; Hunter S
Acta Cytol; 2012; 56(2):155-9. PubMed ID: 22378077
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results.
Diaz-Montes TP; Farinola MA; Zahurak ML; Bristow RE; Rosenthal DL
Gynecol Oncol; 2007 Feb; 104(2):366-71. PubMed ID: 17049972
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
4. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
5. High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?
Twiggs LB; Hopkins M
J Low Genit Tract Dis; 2011 Jul; 15(3):224-30. PubMed ID: 21716051
[TBL] [Abstract][Full Text] [Related]
6. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
8. Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears.
Cuzick J; Ambroisine L; Cadman L; Austin J; Ho L; Terry G; Liddle S; Dina R; McCarthy J; Buckley H; Bergeron C; Soutter WP; Lyons D; Szarewski A
J Med Virol; 2010 Jul; 82(7):1186-91. PubMed ID: 20513082
[TBL] [Abstract][Full Text] [Related]
9. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
[TBL] [Abstract][Full Text] [Related]
10. Screening: Testing times.
Humphries C
Nature; 2012 Aug; 488(7413):S8-9. PubMed ID: 22932440
[No Abstract] [Full Text] [Related]
11. Elevated levels of tetraploid cervical cells in human papillomavirus-positive Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
Olaharski AJ; Eastmond DA
Cancer; 2004 Jun; 102(3):192-9. PubMed ID: 15211479
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HPV-DNA in Pap smears containing ASC and AGC performed within Population Programme of Prophylaxis and Early Detection of Early Cervical Cancer.
Ludwin A; Ludwin I; Pityński K; Jach R; Banaś T; Stangel-Wojcikiewicz K; Horbaczewska A; Pietrus M
Przegl Lek; 2012; 69(11):1189-93. PubMed ID: 23646445
[TBL] [Abstract][Full Text] [Related]
15. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
16. Frequency of human papillomavirus types 16, 18, 31, and 33 and sites of cervical lesions in gynecological patients from Recife, Brazil.
Baldez da Silva MF; Guimarães V; Silva MA; Medeiros do Amaral CM; Beçak W; Stocco RC; Freitas AC; Crovella S
Genet Mol Res; 2012 Mar; 11(1):462-6. PubMed ID: 22427039
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV) types 16 and 18 in liquid-based cervical cytology samples.
Bhar VS; Gupta N; Singh MP; Nijhawan R; Srinivasan R; Suri V; Barward A; Sood S; Rajwanshi A
Virchows Arch; 2015 Jun; 466(6):711-5. PubMed ID: 25758290
[TBL] [Abstract][Full Text] [Related]
18. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
Geraets D; Alemany L; Guimera N; de Sanjose S; de Koning M; Molijn A; Jenkins D; Bosch X; Quint W;
J Pathol; 2012 Dec; 228(4):534-43. PubMed ID: 22711526
[TBL] [Abstract][Full Text] [Related]
19. Lack of agreement between cervicography and cytology and the effect of human papillomavirus infection and viral load.
Schlecht NF; Trevisan A; Baggio ML; Galan L; Duarte-Franco E; Greenberg MD; Rohan TE; Ferenczy A; Villa LL; Franco EL
J Low Genit Tract Dis; 2006 Oct; 10(4):229-37. PubMed ID: 17012988
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and type distribution of high-risk human papillomavirus infections among women in Wufeng County, China.
Zhang L; Wang Y; Peng M; She Q; Xiang Q; Chen Q; Liu Z; Zhang W; Tao N; Qiu L; Wu X
Arch Gynecol Obstet; 2012 Sep; 286(3):695-9. PubMed ID: 22546949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
